Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy M. ProtopapaV. KoulouliasA. Zygogianni Review Article 28 June 2019 Pages: 447 - 456
Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients J. FeliuV. Heredia-SotoM. J. Molina-Garrido Review Article 25 June 2019 Pages: 457 - 467
Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis X. WangL. ChenB. Zhang Research Article 18 June 2019 Pages: 468 - 473
Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis N. WuF. FuC. Wang Research Article Open access 20 June 2019 Pages: 474 - 485
The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo N. DanaS. Haghjooy JavanmardG. Vaseghi Research Article 07 June 2019 Pages: 486 - 494
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial G. Quintero AldanaM. Salgadothe Galician Oncological Research Group (GGIO) Research Article 06 July 2019 Pages: 495 - 502
Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway G. LiR. ZhangY. Feng Research Article 19 June 2019 Pages: 503 - 511
Resection of liver metastases from breast cancer: a multicentre analysis X. HeQ. ZhangL. Wang Research Article Open access 22 June 2019 Pages: 512 - 521
Stromal fibroblast-derived MFAP5 promotes the invasion and migration of breast cancer cells via Notch1/slug signaling Z. ChenX. YanH. Kang Research Article 12 June 2019 Pages: 522 - 531
Red and processed meat consumption and esophageal cancer risk: a systematic review and meta-analysis Z. ZhaoF. WangC. Zhang Research Article 03 July 2019 Pages: 532 - 545
Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification J. CornillieA. WozniakP. Schöffski Research Article 14 June 2019 Pages: 546 - 554
Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients B. FoxM. de Toro CarmenaI. Márquez-Rodas Research Article 29 June 2019 Pages: 555 - 562
ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling X. XuanJ. ZhouW. Yang Research Article 15 June 2019 Pages: 563 - 575
The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients K. ChenJ. QuanZ. Chen Research Article 17 June 2019 Pages: 576 - 584
Breast cancer and cytomegalovirus A. K. RichardsonL. C. WalkerM. J. Currie Research Article 29 June 2019 Pages: 585 - 602
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy A. PassaroP. MancusoF. Bertolini Research Article 28 June 2019 Pages: 603 - 611
Outpatient management of incidental pulmonary embolism in cancer patient Andrés J. Muñoz MartínMagdalena Carmen Ruiz ZamoranoMiguel Martín Jiménez Brief Research Article 13 June 2019 Pages: 612 - 615
Bemiparin as a long-term treatment for venous thrombosis in cancer patients: the ELEBAMA study E. PinaM. AntonioC. Tebe Brief Research Article 19 June 2019 Pages: 616 - 620
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy A. PassaroP. MancusoF. Bertolini Author Correction 20 August 2019 Pages: 621 - 621